Table:
begin	end	state
1	27	cytoplasmic
28	49	transmembrane
50	57	non-cytoplasmic
58	80	transmembrane
81	91	cytoplasmic
92	109	transmembrane
110	115	non-cytoplasmic
116	136	transmembrane
137	155	cytoplasmic
156	179	transmembrane
180	190	non-cytoplasmic
191	210	transmembrane
211	239	cytoplasmic
240	259	transmembrane
260	278	non-cytoplasmic
279	297	transmembrane
298	308	cytoplasmic
309	327	transmembrane
328	333	non-cytoplasmic
334	356	transmembrane
357	367	cytoplasmic
368	390	transmembrane
391	401	non-cytoplasmic
402	420	transmembrane
421	431	cytoplasmic

Input:
>GFF1323 FitnessBrowser__WCS417:GFF1323
MTTTTSHYTGEERSKRIFAIVGASSGNLVEWFDFYVYAFCAIYFAPAFFPSDDPTVQLLN
TAGVFAAGFLMRPIGGWLFGRVADKHGRKNSMMISVLMMCAGSLVIAFLPTYKDIGAWAP
ALLLVARLFQGLSVGGEYGTTATYMSEVALKGQRGFFASFQYVTLIGGQLLAVLVVVILQ
QILTEEELRAWGWRIPFVIGAIAAVISLLLRRTLKETTSKETRQDKDAGSVAALFRNHKA
AFITVLGYTAGGSLIFYTFTTYMQKYLVNTAGMHAKTASYIMTGALFVYMCMQPLFGMLS
DKIGRRNSMLWFGALGTLCTVPILLTLKTVTNPFLAFVLISLALAIVSFYTSISGLVKAE
MFPPHVRALGVGLAYAVANAIFGGSAEYVALGLKSMGMENTFYWYVTGMMAVAFLFSLRL
PKQAEYLHHDL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server